# About NAD Prescribed: An Independent NAD+ Research Digest

> NAD Prescribed is an independent editorial project summarizing the peer-reviewed research on NAD+ and its precursors. Not a clinic, not a vendor, not a prescription service. NAD+ is a coenzyme, not a drug.

A night-edition reading desk for the NAD+ literature — what it is, what it is not, and how it handles the evidence.

## What this publication is

NAD Prescribed is an independent editorial project that publishes summaries of the peer-reviewed research literature on NAD+ and its precursors. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science — a reading of the record, filed like a newspaper's research desk.

## Why "Prescribed"

The word in our name is editorial framing, not a service. "Prescribed" here means what the literature prescribes as evidence — the doses trials actually used, the routes the studies actually tested — not a prescription pad, a pharmacy, or a telehealth funnel. NAD+ is not a prescription medicine; it is an endogenous coenzyme sold, when sold at all, as a dietary supplement, and most often as a precursor. We file the research record on it. We do not prescribe, dispense, or sell, and there is no clinic behind this masthead.

## How we handle the evidence

Three rules govern every page. First, we keep the coenzyme distinct from its precursors: a trial of oral NMN or NR is never described as "taking NAD+," because the molecule and its building blocks are not the same thing. Second, every quantitative claim carries a citation to a named, published study, resolved on the references page to its PubMed record. Third, we describe only what specific studies measured — "in a randomized trial, X mg/day of NMN raised blood NAD+" — and never recommend a dose or a course of use for any person.

Where the evidence is strong, we say so plainly: oral precursors reliably raise blood NAD+. Where it is thin — the injectable route, the hard clinical endpoints, the contested NMN supplement status — we file it under the caution desk in plain view rather than the footnotes. The aim is a sober, accurate reading a curious non-scientist can follow and a careful reader can trust.

---

A night-edition broadsheet on the NAD+ record — the coenzyme filed apart from the NMN and NR precursors that rebuild it, the human trials that raised blood NAD+ kept on their own desk from the poorly-absorbed oral pill and the rapidly-cleared IV drip, and the contested NMN status posted as filed; no clinic behind this masthead and nothing here prescribed, compounded, or sold.